

149
A RANDOMISED CONTROLLED MULTICENTRE TRIAL
11
REFERENCES
1. Chainaki IG, Manolaraki MM, Paspatis G A. Deep sedation for endoscopic retrograde
cholangiopacreatography.
World J Gastrointest Endosc 2011; 3: 34–39
2. Mazanikov M.
Patient-controlled sedation for endoscopic retrograde cholangiopancreatography
.
2013; academic dissertation, Helsinki
3. Kapoor H. Anaesthesia for endoscopic retrograde cholangiopancreatography.
Acta Anaesthesiol Scand 2011; 55: 918–926
4. Hro A, Mann H, Dickersin K, et al. Research and reporting methods annals of internal medicine.
SPIRIT Statement 2013: Defining Standard Protocol Items for Clinical Trials.
Ann Intern Med 2013; 158: 200–207
5. Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy
(ESGE) Guideline: prophylaxis of post-ERCP pancreatitis.
Endoscopy 2010; 42: 503–515
6. Absalom A, Mani V, De Smet T, Struys M. Pharmacokinetic models for propofol-defining and
illuminating the devil in the detail.
Br J Anaesth 2009; 103: 26–37
7. Aldrete J. The post anaesthesia recovery score revisited.
J Clin Anesth 1995; 7: 89–91
8. Mortero RF, Clark LD, Tolan MM, et al. The effects of small-dose ketamine on propofol sedation:
respiration, postoperative mood, perception, cognition, and pain.
Anesth Analg 2001; 92: 1465–1469
9. Mason KP, Green SM, Piacevoli Q. Adverse event reporting tool to standardise the reporting and
tracking of adverse events during procedural sedation: a consensus document from the World
SIVA International Sedation Task Force.
Br J Anaesth 2012; 108: 13–20
10. Coté GA, Hovis RM, Ansstas MA, et al. Incidence of sedation-related complications with propofol
use during advanced endoscopic procedures.
Clin Gastroenterol Hepatol 2010; 8: 137–142
11. Fanti L, Agostoni M, Arcidiacono PG, et al. Target-controlled infusion duringmonitored anaesthesia
care in patients undergoing EUS: propofol alone versus midazolam plus propofol. A prospective
double-blind randomised controlled trial.
Dig Liver Dis
2007; 39: 81–86
12. Paspatis GA, Manolaraki MM, Vardas E, Theodoropoulou GC. Deep sedation for endoscopic
retrograde cholangiopancreatography: intravenous propofol alone versus intravenous propofol
with oral midazolam premedication.
Endoscopy 2008; 40: 308–313
13. Varadarajulu S, Eloubeidi MA, Tamhane A, Wilcox CM. Prospective randomised trial evaluating
ketamine for advanced endoscopic procedures in difficult to sedate patients.
Aliment Pharmacol Ther 2007; 25: 987–997
14. Wehrmann T, Riphaus A. Sedation with propofol for interventional endoscopic procedures: a risk
factor analysis.
Scand J Gastroenterol 2008; 43: 368–374
15. Krystal J, Karper LP, Seibyl JP, et al. Subanaesthetic effects of the noncompetitive NMDA antagonist
ketamine in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Arch Gen Psychatrie 1994; 51: 199–214
16. Nakao S, Nagata A, Miyamoto E, et al. Inhibitory effect of propofol on ketamine-induced c-Fos
expression in the rat posterior cingulate and retrosplenial cortices is mediated by GABA receptor
activation.
Acta Anaesthesiol Scand 2003; 47: 284–290